The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Organic Cation Transporters (OCTs, MATEs), In Vitro and In Vivo Evidence for the Importance in Drug Therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clustal W and Clustal X version 2.0
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,358
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Human non-synonymous SNPs: server and survey
Ramensky, V. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf493 · Cited by 2,280
Structure and Mechanism of the Lactose Permease of Escherichia coli
Abramson, J., Smirnova, I., Kasho, V., Verner, G., Kaback, H. R., & Iwata, S. (2003) · Science · doi:10.1126/science.1088196 · Cited by 1,389
Koepsell, H., Lips, K., & Volk, C. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9254-z · Cited by 988
Self-citationEffect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A., Ianculescu, A. G., Yue, L., Lo, J. C., Burchard, E. G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30558 · Cited by 967
Multiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
Active transport of imatinib into and out of cells: implications for drug resistance
Thomas, J., Wang, L., Clark, R. E., & Pirmohamed, M. (2004) · Blood · doi:10.1182/blood-2003-12-4276 · Cited by 643
Drug excretion mediated by a new prototype of polyspecific transporter
Gründemann, D., Gorboulev, V., Gambaryan, S., Veyhl, M., & Koepsell, H. (1994) · Nature · doi:10.1038/372549a0 · Cited by 643
Self-citationCloning and Characterization of Two Human Polyspecific Organic Cation Transporters
GORBOULEV, V., ULZHEIMER, J. C., AKHOUNDOVA, A., ULZHEIMER-TEUBER, I., KARBACH, U., QUESTER, S., BAUMANN, C., LANG, F., BUSCH, A. E., & KOEPSELL, H. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.871 · Cited by 638
Self-citationSiva, N. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-256b · Cited by 622
Goodman and Gilman's, The Pharmacological Basis of Therapeutics
DiStefano, V. (1986) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/0191-3913-19860501-17 · Cited by 580
A human transporter protein that mediates the final excretion step for toxic organic cations
Otsuka, M., Matsumoto, T., Morimoto, R., Arioka, S., Omote, H., & Moriyama, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506483102 · Cited by 571
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
Self-citationGene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney
Motohashi, H., Sakurai, Y., Saito, H., Masuda, S., Urakami, Y., Goto, M., Fukatsu, A., Ogawa, O., & Inui, K.-I. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134866 · Cited by 508
Transporters and drug therapy: Implications for drug disposition and disease
HO, R., & KIM, R. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.05.011 · Cited by 502
Effect of Genetic Variation in the Organic Cation Transporter 1, OCT1, on Metformin Pharmacokinetics
Shu, Y., Brown, C., Castro, R., Shi, R., Lin, E., Owen, R., Sheardown, S., Yue, L., Burchard, E., Brett, C., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100275 · Cited by 477
Wellcome Trust Case Control Consortium, Trégouët, D.-A., Cardiogenics Consortium, König, I. R., Erdmann, J., Munteanu, A., Braund, P. S., Hall, A. S., Großhennig, A., Linsel-Nitschke, P., et al. (2009) · Nature Genetics · doi:10.1038/ng.314 · Cited by 475
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Self-citationCiarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenstädt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A. H., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090610 · Cited by 444
Self-citationInvolvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
Wang, D.-S., Jonker, J. W., Kato, Y., Kusuhara, H., Schinkel, A. H., & Sugiyama, Y. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034140 · Cited by 441
White, D. L., Saunders, V. A., Dang, P., Engler, J., Zannettino, A. C. W., Cambareri, A. C., Quinn, S. R., Manley, P. W., & Hughes, T. P. (2006) · Blood · doi:10.1182/blood-2005-11-4687 · Cited by 435
Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 431
Tanihara, Y., Masuda, S., Sato, T., Katsura, T., Ogawa, O., & Inui, K.-I. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.010 · Cited by 417
Cloning and Functional Expression of a Human Liver Organic Cation Transporter
Zhang, L., Dresser, M. J., Gray, A. T., Yost, S. C., Terashita, S., & Giacomini, K. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.6.913 · Cited by 417
Kekuda, R., Prasad, P. D., Wu, X., Wang, H., Fei, Y.-J., Leibach, F. H., & Ganapathy, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.26.15971 · Cited by 409
Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity
Filipski, K. K., Mathijssen, R. H., Mikkelsen, T. S., Schinkel, A. H., & Sparreboom, A. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.139 · Cited by 399
Nishimura, M., & Naito, S. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.452 · Cited by 388
Nies, A. T., Koepsell, H., Winter, S., Burk, O., Klein, K., Kerb, R., Zanger, U. M., Keppler, D., Schwab, M., & Schaeffeler, E. (2009) · Hepatology · doi:10.1002/hep.23103 · Cited by 387
Self-citationMolecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter
Gründemann, D., Schechinger, B., Rappold, G., & Schömig, E. (1998) · Nature Neuroscience · doi:10.1038/1557 · Cited by 374
Masuda, S., Terada, T., Yonezawa, A., Tanihara, Y., Kishimoto, K., Katsura, T., Ogawa, O., & Inui, K.-I. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030205 · Cited by 371
Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT1
Kimura, N., Masuda, S., Tanihara, Y., Ueo, H., Okuda, M., Katsura, T., & Inui, K.-I. (2005) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.20.379 · Cited by 360
Tzvetkov, M. V., Vormfelde, S. V., Balen, D., Meineke, I., Schmidt, T., Sehrt, D., Sabolić, I., Koepsell, H., & Brockmöller, J. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.92 · Cited by 349
Self-citationYonezawa, A., Masuda, S., Yokoo, S., Katsura, T., & Inui, K.-I. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110346 · Cited by 344
Busch, A. E., Karbach, U., Miska, D., Gorboulev, V., Akhoundova, A., Volk, C., Arndt, P., Ulzheimer, J. C., Sonders, M. S., Baumann, C., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.342 · Cited by 332
Self-citationWhite, D. L., Saunders, V. A., Dang, P., Engler, J., Venables, A., Zrim, S., Zannettino, A., Lynch, K., Manley, P. W., & Hughes, T. (2007) · Blood · doi:10.1182/blood-2007-06-093617 · Cited by 331
Koepsell, H., Schmitt, B. M., & Gorboulev, V. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0017-x · Cited by 316
Self-citationORGANIC CATION TRANSPORTERS IN INTESTINE, KIDNEY, LIVER, AND BRAIN
Koepsell, H. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.243 · Cited by 310
Self-citationBecker, M. L., Visser, L. E., van Schaik, R. H. N., Hofman, A., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · Diabetes · doi:10.2337/db08-1028 · Cited by 290
Shu, Y., Leabman, M. K., Feng, B., Mangravite, L. M., Huang, C. C., Stryke, D., Kawamoto, M., Johns, S. J., DeYoung, J., Carlson, E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730858100 · Cited by 285
Reduction of metformin renal tubular secretion by cimetidine in man.
Somogyi, A., Stockley, C., Keal, J., Rolan, P., & Bochner, F. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03090.x · Cited by 282
Frequency of C3435T polymorphism of MDR1 gene in African people
Schaeffeler, E., Eichelbaum, M. F., Brinkmann, U., Penger, A., Asante-Poku, S., Zanger, U. M., & Schwab, M. G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05579-9 · Cited by 281
Self-citationOCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
Wang, Z.-J., Yin, O. Q. P., Tomlinson, B., & Chow, M. S. S. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328302cd41 · Cited by 281
Hayer‐Zillgen, M., Brüss, M., & Bönisch, H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704785 · Cited by 278
Wang, L., Giannoudis, A., Lane, S., Williamson, P. R., Pirmohamed, M., & Clark, R. E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100268 · Cited by 277
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Kobayashi, Y., Yamamoto, T., Cha, S. H., Sekine, T., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.918 · Cited by 276
Klein, K., Lang, T., Saussele, T., Barbosa-Sicard, E., Schunck, W.-H., Eichelbaum, M., Schwab, M., & Zanger, U. M. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200512000-00004 · Cited by 269
Self-citationGenetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
Song, I., Shin, H., Shim, E., Jung, I., Kim, W., Shon, J., & Shin, J. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.61 · Cited by 268
Jonker, J. W., Wagenaar, E., van Eijl, S., & Schinkel, A. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7902-7908.2003 · Cited by 265
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
Müller, J., Lips, K. S., Metzner, L., Neubert, R. H. H., Koepsell, H., & Brandsch, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.011 · Cited by 262
Self-citationChen, Y., Li, S., Brown, C., Cheatham, S., Castro, R. A., Leabman, M. K., Urban, T. J., Chen, L., Yee, S. W., Choi, J. H., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832cc7e9 · Cited by 248
Selective Substrates for Non-Neuronal Monoamine Transporters
Gründemann, D., Liebich, G., Kiefer, N., Köster, S., & Schömig, E. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.1 · Cited by 245
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response
Giacomini, K. M., Brett, C. M., Altman, R. B., Benowitz, N. L., Dolan, M. E., Flockhart, D. A., Johnson, J. A., Hayes, D. F., Klein, T., Krauss, R. M., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100087 · Cited by 242
Interaction of Imatinib with Human Organic Ion Carriers
Hu, S., Franke, R. M., Filipski, K. K., Hu, C., Orwick, S. J., de Bruijn, E. A., Burger, H., Baker, S. D., & Sparreboom, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4913 · Cited by 232
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Hofman, A., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.15 · Cited by 229
Jonker, J. W., Wagenaar, E., Mol, C. A. A. M., Buitelaar, M., Koepsell, H., Smit, J. W., & Schinkel, A. H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5471-5477.2001 · Cited by 227
Self-citationPolyspecific Cation Transporters Mediate Luminal Release of Acetylcholine from Bronchial Epithelium
Lips, K. S., Volk, C., Schmitt, B. M., Pfeil, U., Arndt, P., Miska, D., Ermert, L., Kummer, W., & Koepsell, H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0363oc · Cited by 221
Self-citationImplications of genetic polymorphisms in drug transporters for pharmacotherapy
Kerb, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.051 · Cited by 219
Kerb, R., Brinkmann, U., Chatskaia, N., Gorbunov, D., Gorboulev, V., Mornhinweg, E., Keil, A., Eichelbaum, M., & Koepsell, H. (2002) · Pharmacogenetics · doi:10.1097/00008571-200211000-00002 · Cited by 214
Self-citationAmphoux, A., Vialou, V., Drescher, E., Brüss, M., La Cour, C. M., Rochat, C., Millan, M. J., Giros, B., Bönisch, H., & Gautron, S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.005 · Cited by 211
Shikata, E., Yamamoto, R., Takane, H., Shigemasa, C., Ikeda, T., Otsubo, K., & Ieiri, I. (2007) · Journal of Human Genetics · doi:10.1007/s10038-006-0087-0 · Cited by 207
Creatinine Transport by Basolateral Organic Cation Transporter hOCT2 in the Human Kidney
Urakami, Y., Kimura, N., Okuda, M., & Inui, K.-I. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029286.45788.ad · Cited by 207
Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1
Busch, A. E., Quester, S., Ulzheimer, J. C., Waldegger, S., Gorboulev, V., Arndt, P., Lang, F., & Koepsell, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32599 · Cited by 206
Self-citationNeuhoff, S., Ungell, A.-L., Zamora, I., & Artursson, P. (2003) · Pharmaceutical Research · doi:10.1023/a:1025032511040 · Cited by 206
Zwart, R., Verhaagh, S., Buitelaar, M., Popp-Snijders, C., & Barlow, D. P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4188-4196.2001 · Cited by 205
Tsuda, M., Terada, T., Ueba, M., Sato, T., Masuda, S., Katsura, T., & Inui, K.-I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147918 · Cited by 194
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function
Leabman, M. K., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., Clark, A. G., Herskowitz, I., et al. (2002) · Pharmacogenetics · doi:10.1097/00008571-200207000-00007 · Cited by 191
Involvement of Organic Cation Transporter 1 in the Lactic Acidosis Caused by Metformin
Wang, D.-S., Kusuhara, H., Kato, Y., Jonker, J. W., Schinkel, A. H., & Sugiyama, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.844 · Cited by 191
Ahlin, G., Karlsson, J., Pedersen, J. M., Gustavsson, L., Larsson, R., Matsson, P., Norinder, U., Bergström, C. A. S., & Artursson, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8003152 · Cited by 190
Khamdang, S., Takeda, M., Noshiro, R., Narikawa, S., Enomoto, A., Anzai, N., Piyachaturawat, P., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037580 · Cited by 189
Kim, D. H. (., Sriharsha, L., Xu, W., Kamel-Reid, S., Liu, X., Siminovitch, K., Messner, H. A., & Lipton, J. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0145 · Cited by 186
Zhou, K., Donnelly, L. A., Kimber, C. H., Donnan, P. T., Doney, A. S. F., Leese, G., Hattersley, A. T., McCarthy, M. I., Morris, A. D., Palmer, C. N. A., et al. (2009) · Diabetes · doi:10.2337/db08-0896 · Cited by 184
Kimura, H., Takeda, M., Narikawa, S., Enomoto, A., Ichida, K., & Endou, H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.293 · Cited by 182
Metformin Transport by Renal Basolateral Organic Cation Transporter hOCT2
Kimura, N., Okuda, M., & Inui, K.-I. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1193-3 · Cited by 176
Zhang, L., Schaner, M. E., & Giacomini, K. M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37595-0 · Cited by 176
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
Okabe, M., Szakács, G., Reimers, M. A., Suzuki, T., Hall, M. D., Abe, T., Weinstein, J. N., & Gottesman, M. M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0539 · Cited by 173
Baganz, N. L., Horton, R. E., Calderon, A. S., Owens, W. A., Munn, J. L., Watts, L. T., Koldzic-Zivanovic, N., Jeske, N. A., Koek, W., Toney, G. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800466105 · Cited by 172
Tsuda, M., Terada, T., Mizuno, T., Katsura, T., Shimakura, J., & Inui, K.-I. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056242 · Cited by 172
Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney
Wu, X., Huang, W., Ganapathy, M. E., Wang, H., Kekuda, R., Conway, S. J., Leibach, F. H., & Ganapathy, V. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f449 · Cited by 171
Tahara, H., Kusuhara, H., Endou, H., Koepsell, H., Imaoka, T., Fuse, E., & Sugiyama, Y. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088104 · Cited by 171
Self-citationIto, S., Kusuhara, H., Kuroiwa, Y., Wu, C., Moriyama, Y., Inoue, K., Kondo, T., Yuasa, H., Nakayama, H., Horita, S., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163642 · Cited by 154
Jung, N., Lehmann, C., RUBBERT, A., Knispel, M., Hartmann, P., van Lunzen, J., Stellbrink, H., Faetkenheuer, G., & Taubert, D. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.020826 · Cited by 152
Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A)
Terada, T., & Inui, K. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.12.008 · Cited by 146
Hepatic Transport Systems Regulating pHi, Cell Volume, and Bile Secretion
Boyer, J. L., Graf, J., & Meier, P. J. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.002215 · Cited by 145
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
Becker, M. L., Visser, L. E., van Schaik, R. H. N., Albert Hofman, D., Uitterlinden, A. G., & Stricker, B. H. C. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328333bb11 · Cited by 139
TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE
Alnouti, Y., Petrick, J. S., & Klaassen, C. (2006) · Drug Metabolism And Disposition · doi:10.1124/dmd.105.006932 · Cited by 139
Minuesa, G., Volk, C., Molina‐Arcas, M., Gorboulev, V., Erkizia, I., Arndt, P., Clotet, B., Pastor‐Anglada, M., Koepsell, H., & Martínez‐Picado, J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146225 · Cited by 136
Self-citationA Plan to Capture Human Diversity in 1000 Genomes
Kaiser, J. (2008) · Science · doi:10.1126/science.319.5862.395 · Cited by 135
Fujita, T., Urban, T., Leabman, M. K., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20536 · Cited by 133
Terada, T., Masuda, S., Asaka, J., Tsuda, M., Katsura, T., & Inui, K. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9016-3 · Cited by 130
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole*
Moore, K. H. P., Yuen, G. J., Raasch, R. H., Eron, J. J., Martin, D., Mydlow, P. K., & Hussey, E. K. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90183-6 · Cited by 129
Ciarimboli, G. (2008) · Xenobiotica · doi:10.1080/00498250701882482 · Cited by 128
Zolk, O., Solbach, T. F., König, J., & Fromm, M. F. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0369-5 · Cited by 127
Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters
Bachmakov, I., Glaeser, H., Fromm, M. F., & König, J. (2008) · Diabetes · doi:10.2337/db07-1515 · Cited by 125
Nies, A. T., Herrmann, E., Brom, M., & KEPPLER, D. O. R. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0219-x · Cited by 124
Self-citationFunctional Analysis of Organic Cation Transporter 3 Expressed in Human Placenta
Sata, R., Ohtani, H., Tsujimoto, M., Murakami, H., Koyabu, N., Nakamura, T., Uchiumi, T., Kuwano, M., Nagata, H., Tsukimori, K., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086827 · Cited by 123
Sakata, T., Anzai, N., Shin, H. J., Noshiro, R., Hirata, T., Yokoyama, H., Kanai, Y., & Endou, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.175 · Cited by 116
Verhaagh, S., Schweifer, N., Barlow, D. P., & Zwart, R. (1999) · Genomics · doi:10.1006/geno.1998.5639 · Cited by 115
Altered aminergic neurotransmission in the brain of organic cation transporter 3‐deficient mice
Vialou, V., Balasse, L., Callebert, J., Launay, J., Giros, B., & Gautron, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05506.x · Cited by 114
Membrane Localization of the Electrogenic Cation Transporter rOCT1 in Rat Liver
Meyer‐Wentrup, F. A. G., Karbach, U., Gorboulev, V., Arndt, P., & Koepsell, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9034 · Cited by 112
Self-citationYokoo, S., Masuda, S., Yonezawa, A., Terada, T., Katsura, T., & Inui, K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023168 · Cited by 112
Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1
Bednarczyk, D., Ekins, S., Wikel, J. H., & Wright, S. H. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.489 · Cited by 111
Gründemann, D., Hahne, C., Berkels, R., & Schömig, E. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044404 · Cited by 109
Bourdet, D. L., Pritchard, J. B., & Thakker, D. R. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091223 · Cited by 109
Organic Cation Transporter 3 (Slc22a3) Is Implicated in Salt-Intake Regulation
Vialou, V., Amphoux, A., Zwart, R., Giros, B., & Gautron, S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5147-03.2004 · Cited by 109
Kang, H., Song, I., Shin, H. J., Kim, W., Lee, C., Shim, J.-C., Zhou, H., Lee, S. S., & Shin, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013581 · Cited by 108
Schmitt, A., Mössner, R., Gossmann, A., Fischer, I., Gorboulev, V., Murphy, D., Koepsell, H., & Lesch, K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10521 · Cited by 106
Self-citationMatsushima, S., Maeda, K., Inoue, K., Ohta, K., Yuasa, H., Kondo, T., Nakayama, H., Horita, S., Kusuhara, H., & Sugiyama, Y. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023911 · Cited by 104
Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function
Chen, Y., Teranishi, K. S., Li, S., Yee, S. W., Hesselson, S., Stryke, D., Johns, S. J., Ferrin, T. E., Kwok, P., & Giacomini, K. M. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2008.19 · Cited by 102
Transport of Dicationic Drugs Pentamidine and Furamidine by Human Organic Cation Transporters
Ming, X., Ju, W., Wu, H., Tidwell, R. R., Hall, J. E., & Thakker, D. R. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024083 · Cited by 97
van Montfoort, J. E., Müller, M. M., Groothuis, G. M. M., Meijer, D. K. F., Koepsell, H., & Meier, P. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29357-5 · Cited by 94
Self-citationFeng, B., Obach, R., Burstein, A., Clark, D., de Morais, S., & Faessel, H. M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100405 · Cited by 93
Dresser, M. J., Xiao, G., Leabman, M. K., Gray, A. T., & Giacomini, K. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1019870831174 · Cited by 92
Mechanism of Electrogenic Cation Transport by the Cloned Organic Cation Transporter 2 from Rat
Budiman, T., Bamberg, E., Koepsell, H., & Nagel, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004645200 · Cited by 92
Self-citationInazu, M., Takeda, H., & Matsumiya, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01566.x · Cited by 91
Gorboulev, V., Shatskaya, N. V., Volk, C., & Koepsell, H. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008821 · Cited by 91
Self-citationRegulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases
Çetinkaya, I., Ciarimboli, G., Yalçinkaya, G., Mehrens, T., Velić, A., Hirsch, J. R., Gorboulev, V., Koepsell, H., & Schlatter, E. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00251.2002 · Cited by 90
Self-citationRegulation of the human organic cation transporter hOCT1
Ciarimboli, G., Struwe, K., Arndt, P., Gorboulev, V., Koepsell, H., Schlatter, E., & Hirsch, J. R. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20081 · Cited by 87
Self-citationIn vitroevidence for the role of OATP and OCT uptake transporters in drug–drug interactions
Kindla, J., Fromm, M. F., & König, J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902911463 · Cited by 85
Ballestero, M. R., Monte, M. J., Briz, Ó., Jimenez, F., Martin, F. G.-S., & Marı́n, J. J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.007 · Cited by 84
Ohta, K., Inoue, K., Hayashi, Y., & Yuasa, H. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010876 · Cited by 78
Zhang, L., Gorset, W., Washington, C. B., Blaschke, T. F., Kroetz, D. L., & Giacomini, K. M. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15369-x · Cited by 77
Estimating the number of unseen variants in the human genome
Ionita‐Laza, I., Lange, C., & Laird, N. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807815106 · Cited by 75
Dudley, A. J., Bleasby, K., & Brown, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703518 · Cited by 75
The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26
Koehler, M. R., Wissinger, B., Gorboulev, V., Koepsell, H., & Schmid, M. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134720 · Cited by 74
Self-citationRole of transport proteins in drug discovery and development: a pharmaceutical perspective
Ayrton, A. D., & Morgan, P. (2008) · Xenobiotica · doi:10.1080/00498250801923855 · Cited by 70
Shnitsar, V., Eckardt, R., Gupta, S., Grottker, J., Muller, G. A., Koepsell, H., Burckhardt, G., & Hagos, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2483 · Cited by 69
Self-citationCharacterization of regulatory mechanisms and states of human organic cation transporter 2
Biermann, J., Lang, D., Gorboulev, V., Koepsell, H., Sinđić, A., Schröter, R., Žvirblienė, A., Pavenstädt, H. J., Schlatter, E., & Ciarimboli, G. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00622.2005 · Cited by 69
Self-citationDecreased anxiety in mice lacking the organic cation transporter 3
Wultsch, T., Grimberg, G., Schmitt, A. G., Painsipp, E., Wetzstein, H., Breitenkamp, A. F., Gründemann, D., Schömig, E., Lesch, K., Gerlach, M., et al. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0205-1 · Cited by 69
Abel, S., Nichols, D. J., Brearley, C. J., & Eve, M. D. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00114.x · Cited by 68
Lee, W.-K., Reichold, M., Edemir, B., Ciarimboli, G., Warth, R., Koepsell, H., & Thévenod, F. (2009) · AJP - Renal Physiology · doi:10.1152/ajprenal.90754.2008 · Cited by 65
Self-citationGorbunov, D., Gorboulev, V., Shatskaya, N. V., Mueller, T. D., Bamberg, E., Friedrich, T., & Koepsell, H. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.040170 · Cited by 61
Self-citationMinematsu, T., Iwai, M., Umehara, K., Usui, T., & Kamimura, H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028142 · Cited by 57
Gene structures of the human non-neuronal monoamine transporters EMT and OCT2
Gründemann, D., & Schömig, E. (2000) · Human Genetics · doi:10.1007/s004390000309 · Cited by 54
Association Between Gene Polymorphisms of SLC22A3 and Methamphetamine Use Disorder
Aoyama, N., Takahashi, N., Kitaichi, K., Ishihara, R., Saito, S., Maeno, N., Ji, X., Takagi, K., Sekine, Y., Iyo, M., et al. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00215.x · Cited by 52
Interaction of beta‐blockers with the renal uptake transporter OCT2
Bachmakov, I., Glaeser, H., Endreß, B., Mörl, F., König, J., & Fromm, M. F. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01076.x · Cited by 50
Interactions of Organic Anion Transporters and Organic Cation Transporters With Mycotoxins
Tachampa, K., Takeda, M., Khamdang, S., Noshiro, R., Tsuda, M., Jariyawat, S., Fukutomi, T., Sophasan, S., Anzai, N., & Endou, H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070911 · Cited by 50
Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2
Kimura, N., Masuda, S., Katsura, T., & Inui, K. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.010 · Cited by 49
Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney
Ogasawara, K., Terada, T., Motohashi, H., Asaka, J., Aoki, M., Katsura, T., Kamba, T., Ogawa, O., & Inui, K. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0288-9 · Cited by 48
Itoda, M., Saito, Y., Maekawa, K., Hichiya, H., Komamura, K., Kamakura, S., Kitakaze, M., Tomoike, H., Ueno, K., Ozawa, S., et al. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.308 · Cited by 48
Lazar, A., Walitza, S., Jetter, A., Gerlach, M., Warnke, A., Herpertz‐Dahlmann, B., Gründemann, D., Grimberg, G., Schulz, E., Remschmidt, H., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007742 · Cited by 48
Matsumoto, T., Kanamoto, T., Otsuka, M., Omote, H., & Moriyama, Y. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00504.2007 · Cited by 42
Hesselson, S., Matsson, P., Shima, J. E., Fukushima, H., Yee, S. W., Kobayashi, Y., Gow, J. M., Ha, C. W. Y., Ma, B., Poon, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006942 · Cited by 41
Umehara, K., Iwatsubo, T., Noguchi, K., Usui, T., & Kamimura, H. (2008) · Xenobiotica · doi:10.1080/00498250802334409 · Cited by 39
Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)
Lazar, A., Gründemann, D., Berkels, R., Taubert, D., Zimmermann, T., & Schömig, E. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0015-5 · Cited by 39
Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs
Hasannejad, H., Takeda, M., Narikawa, S., Huang, X.-L., Enomoto, A., Taki, K., Niwa, T., Jung, S. H., Onozato, M. L., Tojo, A., et al. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.098 · Cited by 37
Cheng, Y., Wright, S. H., Hooth, M. J., & Sipes, I. G. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022681 · Cited by 26
Are organic cation transporters capable of transporting prostaglandins?
Harlfinger, S., Fork, C., Lazar, A., Schömig, E., & Gründemann, D. (2005) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-005-0011-8 · Cited by 25
Lower Prevalence of the OCT2 Ser270 Allele in Patients with Essential Hypertension
Lazar, A., Zimmermann, T., Koch, W., Gründemann, D., Schömig, A., Kastrati, A., & Schömig, E. (2006) · Clinical and Experimental Hypertension · doi:10.1080/10641960600946411 · Cited by 22
Iwai, M., Minematsu, T., Narikawa, S., Usui, T., & Kamimura, H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027359 · Cited by 17
Renal transport of drugs: an overview of methodology with application to cimetidine.
Giacomini, K. M., Hsyu, P., & Gisclon, L. G. (1988) · Pharmaceutical Research · doi:10.1023/a:1015904905235 · Cited by 8
Cited by
Metformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Roth, M., Obaidat, A., & Hagenbuch, B. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01724.x · Cited by 767
Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
König, J., Müller, F., & Fromm, M. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007518 · Cited by 575
Metformin pathways: pharmacokinetics and pharmacodynamics
Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283559b22 · Cited by 495
Metadata
- Authors
- Nies, A. T., Koepsell, H., Damme, K., & Schwab, M.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer Berlin Heidelberg
- Published
- 2010-10-26
- Issue
- 201
- Pages
- 105-167
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W2235836043
- Cited by
- 375
- References
- 154
- FWCI
- 47.30
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.